NSD2 and cancer: We chose ERK, TGFB1, TGFB2, SIRT1, IL-6, PI3K, and WHSC1 (which were controlled by several genes) and three other genes AR, BCL-XL, and CCND1 that could mark the deterioration of the cancer, for testing.